MedTrace Logo

Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers

NCT01143727 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2013-05-31

Study results available
· View outcomes & findings →

Summary

This study compares two standard methods for cleaning the surface of wounds on the feet of patients with diabetes mellitus. The question being asked is whether inflammation of the wound affects the ability of one or both of the methods to work.

Conditions

  • Diabetic Foot Ulcers

Interventions

DRUG

Santyl

Apply one 24-hr period sufficient to cover the wound.

DRUG

Tegaderm Hydrogel

Apply once 24-hr period sufficient to cover the wound.

Sponsors & Collaborators

  • Healthpoint

    lead INDUSTRY

Principal Investigators

  • Herbert B Slade, MD · Healthpoint

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01143727 on ClinicalTrials.gov